Table 3.

Diagnosis Information and Site of Infection^a,b

Variable	N	Overall (N=110)	Nontransplant patients (n=56)	Transplant patients (n=54)	P value
Diagnosis information
First specimen source
Bronchoalveolar lavage/brushing	110	44 (40.0)	15 (26.8)	29 (53.7)	.006
Sputum/induced sputum/tracheal aspirate	110	19 (17.3)	14 (25.0)	5 (9.3)	.042
Pleural fluid	110	3 (2.7)	0 (0.0)	3 (5.6)	.12
Transbronchial, surgical, or percutaneous lung biopsy	110	8 (7.3)	3 (5.4)	5 (9.3)	.49
Abscess solid organ biopsy	110	1 (0.9)	0 (0.0)	1 (1.9)	.49
Cutaneous biopsy/swab/skin abscess	110	23 (20.9)	16 (28.6)	7 (13.0)	.060
Blood culture	110	7 (6.4)	4 (7.1)	3 (5.6)	1.00
Cerebrospinal fluid	110	1 (0.9)	1 (1.8)	0 (0.0)	1.00
Brain abscess biopsy	110	3 (2.7)	2 (3.6)	1 (1.9)	1.00
Otherc	110	2 (1.8)	1 (1.8)	1 (1.9)	1.00
Chest radiography at diagnosis	110	91 (82.7)	42 (75.0)	49 (90.7)	.042
Chest CT scan at diagnosis	110	94 (85.5)	45 (80.4)	49 (90.7)	.18
Brain CT scan at diagnosis	110	46 (41.8)	18 (32.1)	28 (51.9)	.053
Brain MRI at diagnosis	110	50 (45.5)	19 (33.9)	31 (57.4)	.021
Site of infection
Disseminated infection	110	23 (20.9)	12 (21.4)	11 (20.4)	1.00
Lung	110	81 (73.6)	37 (66.1)	44 (81.5)	.084
Skin and soft tissue	110	26 (23.6)	16 (28.6)	10 (18.5)	.26
Brain/cerebrospinal fluid/eye	110	13 (11.8)	6 (10.7)	7 (13.0)	.77
Joint	110	2 (1.8)	1 (1.8)	1 (1.9)	1.00
Liver	110	0 (0.0)	0 (0.0)	0 (0.0)	1.00
Bacteremia	110	3 (2.7)	1 (1.8)	2 (3.7)	.61
Otherd	110	4 (3.6)	1 (1.8)	3 (5.6)	.36

^aCT = computed tomography; MRI = magnetic resonance imaging.

^bData are presented as No. (percentage). P values comparing nontransplant and transplant patient results from the Fisher exact test.

^cEndophthalmitis and peritoneal fluid.

^dEye, peritoneum, and salivary gland.